Spine: A Non-vertebral: B Hip: B
In addition to the evidence that cyclic etidronate reduces vertebral fracture rate in postmenopausal women, data from the GP research database in 7,977 patients on cyclic etidronate and 7.977 age/sex matched controls reported a reduction in non-vertebral fracture by 20% and hip fracture by 34%.
Add information to this page that would be handy to have on hand during a consultation, such as a web address or phone number. This information will always be displayed when you visit this page